Incyte (INCY) Misses Q3 EPS by 7c, Beats on Revenue; Offers FY26 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 116.01 -0.86 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.87 | 52 Week High | $118.49 | |||
| Open | $111.64 | 52 Week Low | $55.00 | |||
| Day High | $117.08 | P/E | N/A | |||
| Day Low | $111.01 | EPS | $-0.56 | |||
| Volume | 2,026,675 | |||||
